CAS No.:940-69-2

TOXICITY DATA with REFERENCE：

1.		orl-rat LD50:1980 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),454.
2.		ipr-rat LD50:250 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),454.
3.		scu-rat LD50:1700 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),454.
4.		orl-mus LD50:620 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),454.
5.		ipr-mus LD50:310 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),454.
6.		scu-mus LD50:3500 mg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982” Edited by Japan Pharmaceutical Information Center. 6 (1982),454.

Consensus Reports：

 

SAFETY PROFILE：

Poison by intraperitoneal route. Moderately toxic by ingestion and subcutaneous routes. When heated to decomposition it emits toxic fumes of SO_x and NO_x.
Risk Statements about ( /-)-alpha-Lipoamide (CAS No.940-69-2):
R22:Harmful if swallowed.
Safety Statements about ( /-)-alpha-Lipoamide (CAS No.940-69-2):
S22:Do not breathe dust. 
S24/25:Avoid contact with skin and eyes.

Standards and Recommendations：

 

Analytical Methods：